Initially, our data showed that high expression levels of HIF-1α in clinical tumor specimens were correlated with advanced tumor stage and poor differentiation, suggesting that HIF-1α is a potential biomarker for NB progression (Table 1 and Fig. 1). The gene discussed is HIF1A; the disease is neoplasm.